Easton Pharmaceuticals Announces It Has Engaged Online Marketing and Branding Specialists to Support the Firm’s Updated Products, Branding and Website Launch; Provides Update on Its Medical Marijuana Initiatives

Posted by on Mar 19, 2014 in News | 0 comments

TORONTO, ONTARIO–(Marketwired – Mar 19, 2014) – ¬†Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has hired marketing and branding specialists to support the firms brand and online marketing awareness, as well as provide an update on its medical marijuana initiatives.

Easton Pharmaceuticals has recognized that its website, online marketing strategy and branding needed improving. As a result, Easton has engaged the services of a leading Toronto-based branding agency who have established itself in the industry with being able to assist companies such as Easton Pharmaceuticals to gain brand recognition while possessing strong sales and marketing skills to effectively promote the company’s products and website awareness. The company utilizes some of the most proficient digital solutions managers for website development. Easton Pharmaceuticals has been in the process of revamping the company’s website which is expected to be online no later than the beginning of next week which will also eventually allow the company’s products to be purchased directly through its website. In addition, Easton is revamping its product line which includes packaging, naming of products, brochures and literature which will be showcased on the company’s updated website, set to be unveiled in the next few days.

In other developments, Easton Pharmaceuticals, as previously stated by the company, is presently in the process of drafting and executing, through their respective attorneys, a final definitive agreement towards its Medical Marijuana Initiatives. The Company apologizes for the many delays, but most have not been in the control of the company. Easton has been in negotiations with various companies, some of which have been disclosed, which has now been narrowed down to a joint partnership for the intended acquisition of up to 3 companies and property who have applied for MMPR licenses for all of Canada, been granted an approval to build out what are considered very large facilities as mandated per MMPR regulations and have been growing Marijuana for current dispensaries including the supplying of Marijuana for Research & Development to various institutions. All of which have added to the complexity of the negotiations. Easton Pharmaceuticals believes its patented transdermal delivery system can one day in the near future be used to administer drugs for the treatment of various ailments and conditions utilizing certain agents derived from Marijuana. As stated, it is the company’s full intention on utilizing its cash position towards an acceptable agreement to enter into what is believed to be the bourgeoning medical marijuana industry.

Leave a Reply

Your email address will not be published. Required fields are marked *

* Copy This Password *

* Type Or Paste Password Here *